During the past decade, Jiangsu Province Hospital of Chinese Medicine conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 2 clinical trials were completed. i.e. 6.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jiangsu Province Hospital of Chinese Medicine" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Jiangsu Famous Medical Technology Co., Ltd." with 3 trials sponsored, "Nanjing University of Traditional Chinese Medicine" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Beijing Tiantan Hospital" with 2 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jiangsu Province Hospital of Chinese Medicine" #1 collaborator was "Jiangsu Province Hospital of Traditional Chinese Medicine" with 3 trials as a collaborator, "Ministry of Science and Technology of the People´s Republic of China" with 3 trials as a collaborator, "Affiliated Hospital of Nanjing University of Traditional Chinese Medicine" with 2 trials as a collaborator, "Chinese Medicine Hospital Affiliated to Southwest Medical University" with 2 trials as a collaborator and "First Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Jiangsu Province Hospital of Chinese Medicine" are "Carotid Artery Diseases" (2 trials), "Crohn's Disease" (2 trials), "HPV Infection" (2 trials), "Irritable Bowel Syndrome" (2 trials) and "Stomach Neoplasms" (2 trials). Many other conditions were trialed in "Jiangsu Province Hospital of Chinese Medicine" in a lesser frequency.

Most popular intervention types in "Jiangsu Province Hospital of Chinese Medicine" are "Drug" (33 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Mirikizumab" (3 trials), "2.5mg of BAT5906" (2 trials), "Atractylodes" (2 trials) and "Fingered citron" (2 trials). Other intervention names were less common.

The vast majority of trials in "Jiangsu Province Hospital of Chinese Medicine" are 45 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jiangsu Province Hospital of Chinese Medicine". 1 are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Jiangsu Province Hospital of Chinese Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jiangsu Province Hospital of Chinese Medicine, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 11 trials that are defined as “Not Applicable".